← All organizations

ProfoundBio US Co.

For profitWebsite ↗

Also known as: ProfoundBio US Co.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 31, 2024

Acquired by Genmab on Apr 3, 2024

Timeline

2010s

Jan 1, 2018
ProfoundBio US Co.— Founded

2020s

Apr 3, 2024
Genmab— Acquired By

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (3 own, 0 via acquisition)

Recent trials (3)

NCT06171789Lead sponsorPhase 1/Phase 2Jan 31, 2024
NCT05721222Lead sponsorPhase 1/Phase 2Mar 15, 2023
NCT05579366Lead sponsorPhase 1/Phase 2Dec 7, 2022

Details

Founded: Suzhou, CN Jan 1, 2018
Last known activity: Jan 31, 2024